NeuroPace NPCE
NASDAQ NPCE
$14.00 -0.64 (-4.37%)
At close: Aug 20, 2026 · 12:03 PM UTC

NeuroPace (NPCE) Gross Margin (2020 - 2026)

NeuroPace (NPCE) posted quarterly Gross Margin of 81.78% for Q1 2026, up 479.0% year-over-year from 14.12% in Q1 2025, and up 5.67% quarter-over-quarter from 77.4% in Q4 2025.

NeuroPace (NPCE) Gross Margin (2020 - 2026) Analysis & Trends

NeuroPace's Gross Margin history runs 7 years deep, the most recent figure standing at 81.78% for Q1 2026.

  • In Q1 2026, Gross Margin rose 479.0% year-over-year to 81.78%; the TTM figure through Mar 2026 stood at 78.29% (up 347.0% YoY), while the FY2025 annual figure was 77.23%, up 329.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 81.78%, up from 77.4% in the prior quarter.
  • The five-year high for Gross Margin was 81.78% in Q1 2026, with the low at 68.83% in Q4 2022.
  • The 5-year median for Gross Margin is 73.62% (2024), against an average of 74.48%.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 461 bps in 2022, then soared 637 bps in 2023.
  • NeuroPace's Gross Margin stood at 68.83% in 2022, then rose by 9 bps to 75.2% in 2023, then rose by 0 bps to 75.41% in 2024, then rose by 3 bps to 77.4% in 2025, then climbed by 6 bps to 81.78% in 2026.
  • Business Quant data shows NPCE's Gross Margin at 81.78% in Q1 2026, 77.4% in Q4 2025, and 77.39% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn 57.71%
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn 68.27%
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn 65.35%
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn 70.71%
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn 77.46%
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn 63.44%
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn 41.17%
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn 47.38%
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn 45.84%
10 NeuroPace 477.46 Mn 425.76 Mn 18.91 Mn 82.83%

Historic Data

Download Data
DateValue
Jun 30, 2026 82.83%
Mar 31, 2026 81.78%
Dec 31, 2025 77.40%
Sep 30, 2025 77.39%
Jun 30, 2025 77.09%
Mar 31, 2025 76.99%
Dec 31, 2024 75.41%
Sep 30, 2024 73.22%
Jun 30, 2024 73.40%
Mar 31, 2024 73.62%
Dec 31, 2023 75.20%
Sep 30, 2023 74.47%
Jun 30, 2023 72.51%
Mar 31, 2023 71.67%
Dec 31, 2022 68.83%
Sep 30, 2022 71.39%
Jun 30, 2022 73.20%
Mar 31, 2022 72.61%
Dec 31, 2021 73.44%
Sep 30, 2021 72.61%